Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort

By afschroeder • August 22, 2025

Razavi AC, Chen J, Yang W, Sha D, Dzaye O, Bhatia HS, Tsimikas S, Lash JP, Kansal M, Rincon-Choles H, Vaccarino V, Jacobson TA, Budoff MJ, Blumenthal RS, Whelton SP, Sperling LS, Blaha MJ, He J; CRIC Study Investigators. Primary Prevention Aspirin, Lipoprotein(a), and Cardiorenal Outcomes in Chronic Kidney Disease: Chronic Renal Insufficiency Cohort. JACC Adv. 2025 Aug 19;4(9):102068. doi: 10.1016/j.jacadv.2025.102068. Epub ahead of print. PMID: 40839904.

Tags: Aspirin, Cardiology/Epi, cardiovascular diseases, Chronic kidney disease, Harbor UCLA, lipoprotein(a), Publications

Coronary artery calcium score of zero in individuals with diabetes: association with normal coronary arteries and cardiovascular risk factors

Phan JP, Kinninger A, Roy SK, Bhandari M, Budoff MJ. Coronary artery calcium score of zero in individuals with diabetes: association with normal coronary arteries[...]

Richard Cheng, MD Appointed Associate Director of Interventional Cardiology

We are pleased to announce the appointment of Richard Cheng, MD as the new associate director of interventional cardiology (IC) in the UCLA Department of Medicine Division of Cardiology. In this capacity, Dr. Cheng will[...]

Association of Ramus intermedius with increased atherosclerotic plaque in the left main stem

Pourafkari L, Ansari S, Kinninger A, Budoff MJ. Association of Ramus intermedius with increased atherosclerotic plaque in the left main stem. Int J Cardiovasc Imaging.[...]